Superior Efficacy and Improved Renal and Bone Safety After Switching From a Tenofovir Disoproxil Fumarate (TDF)- to a Tenofovir Alafenamide (TAF)-based Regimen Through 96 Weeks of Treatment
DeJesus, Edwin, Haas, Bernard, Segal-Mauer, Sorana, Ramgopal, Moti, Mills, Anthony, Margot, Nicolas, Liu, Ya-Pei, Makadzange, Tariro, McCallister, ScottLanguage:
english
Journal:
AIDS Research and Human Retroviruses
DOI:
10.1089/AID.2017.0203
Date:
January, 2018
File:
PDF, 513 KB
english, 2018